Through procedural developments and cooperative research, we are breaking new ground in saving sight, speech, and hearing.
We are committed to spreading Helen Keller’s legacy of courage and selflessness to our communities and future generations.
2018 Helen Keller Laureates
Webster Cavenee, Ph.D, Thaddeus P. Dryja, M.D., Brenda L. Gallie, M.D., A. Linn Murphree, M.D.
By the 1970’s, oncogenes had been identified as genes that cause or predispose to human cancer by being activated or inappropriately turned on. In the early to mid 1980’s, teams led by ophthalmologists Ted Dryja, Brenda Gallie and Linn Murphree along with basic scientists, primarily Web Cavenee, successfully mapped (read more)